Dear potential LIS providers,
Based on feedback we have received from some LIS providers, we are extending the deadline for the RFP responses to be received by June 4. We hope this will allow you more time to put together your proposals. Additionally, while we were required to divide the work into phases, we request that you provide your estimated timeline required to do the work, divided into Phase 1 and Phase 2. The start and end dates of the Phases can be negotiated at the time of the vendors conference and final selection. Similarly, while we have provided a range of our estimated budget, we request that you still submit your estimated costs as the budget is not scored during the initial evaluation.
New RFP Deadline: June 4, 2021
APHL is soliciting offers from qualified information technology software providers with offices and operations in Indonesia to implement LIS in four B/BTKL-PP Ministry of Health laboratories in Indonesia. The successful proposal will provide a cost-effective LIS that can be maintained reliably in a timely manner and will offer an affordable solution that can be sustained in a resource-poor setting. APHL, working together with the Indonesia MOH and US CDC, surveyed four laboratories to identify and implement the first phase of the LIS in Indonesia. Phase 1 will provide objective information for development of a national plan for LIS implementation that addresses the technical, human resource, support and financial issues for a LIS. The four laboratories selected for the Phase 1 project are BBTKL-PP Yogyakarta, BBTKL-PP Surabaya, BBTKL-PP Banjarbaru, and BTKL-PP Batam.
APHL assisted US CDC and the Indonesia MoH in the performance of an evaluation of the laboratory system needs for a LIS and to develop an implementation plan for the Phase 1 laboratories. The assessment team activities included the following:
- Survey of operations in the Phase 1 laboratories and meetings with stakeholders, in order to describe standard laboratory services and current LIS capacity in the public health sector of Indonesia;
- Visits to B/BTKL-PP laboratories to compare sample flow procedures and understand how samples are processed;
- Discussion meetings on LIS requirements with Indonesia MOH surveillance leadership and MOH Data and Information Center, as well as with CDC Indonesia staff and leadership;
- Initiated development of an action plan and implementation schedule for the LIS in Indonesia; and
- Compiled the specific information, request and report forms and requirements for the development of an RFP for the purchase of a LIS.
- RFP Issued: April 21, 2021
- Webinar: May 5, 2021
- Questions due: May 5, 2021
- Responses due: June 4, 2021
- Award selection: June 25, 2021
The initial award will be made through September 29, 2021. Any subsequent awards will be made during the following financial year for APHL's cooperative agreement with CDC.
This RFP solicits offers from software providers with offices and operations in Indonesia that can deploy the LIS in Bahasa Indonesia and provide maintenance and support in Bahasa as well.
The Indonesia Ministry of Health may require the source code of the LIS solution selected. Alternatively the LIS source code may be placed in escrow for the duration of the project.
The LIS vendor/provider will agree to provide administrator level training to APHL and designated Ministry of Health staff. This will enable the trainees to carry out configurations, enhancements and maintenance tasks.
May 5, 2021, APHL held a webinar to review the RFP and capture questions. Applicants can access the
webinar recording at any time
(make sure to access the recording in a Incoginto or Inprivate browser window).
RFP Related Questions
All questions should be submitted in writing via email to Reshma Kakkar, Informatics Manager, Global Health,
email@example.com, no later than May 5, 2021. Questions will be addressed on APHL's
Submission of RFP
Responses must be sent to APHL by e-mail attachment in MSWord or PDF format (electronic signatures accepted) to Reshma Kakkar, Informatics Manager, Global Health, via email at
firstname.lastname@example.org. E-mail attachment is the preferred means of receipt. E-mail responses must be received at the APHL office by 5 pm WIB (Western Indonesia Time zone)/6 am Eastern time (U.S) on May 21, 2021. Submitters will receive a confirmation of receipt of their RFP by APHL. If submitters do not receive a confirmation within 48 hours of sending the response, submitters should reach out to Reshma Kakkar (email@example.com) for confirmation. APHL may terminate or modify the RFP process at any time during the response period.
Responses that are not received by the stated deadline shall be determined to be non-responsive and at APHL's discretion may not be considered in the review of respondents.
The Official RFP Document will provide detailed information in regards to this request, please read it on its entirety. Additionally, please download the
fillable Appendices A-H.
Questions and Answers
From the RFP information, the initial award will be made through on September 29th. Kindly confirm if this is the date expected for Phase I system commission date? If not, could the board inform the expected timeline for the Phase I project?
From the RFP information, there is section about Compensation Amount for the initial award. Kindly confirm if the estimation is the actual project budget for Phase I.
In the Submission Form for specimen registration, there are fields to capture amount paid and receipt number. Kindly confirm if LIS will have system interface with other billing system OR LIS to provide billing system in Phase I
In Phase I requirement for data exchange/electronic laboratory reporting, kindly confirm if LIS only need to interface with proposed system: Sharing laboratory data with central laboratory data repository at MoH, Data visualization/dashboard, Electronic test order from remote clinic bi-directional from LIS system.
In Phase I requirement, the pilot of electronic test order requirement is to be able to connect to separate test order system for registration and result data information. Kindly confirm: if that separate system will be using the same system for all B/BTKL-PP sites registration? (i.e. single system used in all referral facilities and can be interfaced to LIS database).
Kindly confirm if the e-TOR will be used 100% for all test order?
In Phase I, there is requirement about capability of electronic referral to external laboratories. Kindly confirm if this means LIS to be able to interface records to and from external laboratory.
Kindly inform how many report format (patient result, summary or aggregate, and management) exists and expected to be generated in LIS.
Kindly explain the requirement to produce reports for positive tests results and de-identified aggregate health data in any given time period. Is this kind of scheduled report generated in LIS?
Kindly explain the requirement for cumulative weekly and monthly quality control reports.
For the requirement of personnel inventory, there is a requirement for training record. Kindly confirm if training management is included in Phase I project.
Currently we do not provide source code to user. Kindly confirm that this is a necessary item.
Is it necessary to provide the operation of biological tests listed? If yes, to what extent in detail should we describe? Is there any example?
We are a software developer from India with partner in Indonesia. Can we bid as the product owner giving details of our partner in Indonesia? or is only our partner can bid?
For the installation of software and use at different labs, Can this be installed in a central location from cloud or MOH Infra and used by each lab via internet or WAN or VPN?
You mention that travel funds will not be covered by APHL. Does this include travels required to install the application and/or train the staff at the lab?
Communications will be in English or Bahasa?
You have mentioned that there are 8 PCs in each lab then for 4 labs it should be 32 seats or 32 concurrent users right?
$50,000-$85,000 is the budget of this project, right?
My office is in Indonesia, located in Palu. central Sulawesi. will we also collaborate with local Health Department?
How to I learn and can get information about infrastructure in lab (Surabaya Team)
For a feature or module that must be developed if needed, how much is the maximum allowed? For example, there is no virology in our system, then we build it first, is that allowed?
If we need to install back-up internet access (to ensure the lab remains online if the main internet provider breaks down), will that be procured by APHL?
If we only have a branch office in Indonesia, but our legal office is outside Indonesia, will we still be able to bid?
Is there any APHL Person in Charge that we can contact?
IF we have recommendation in change or add infrastructure/feature in RFP?
29 Sept phase 1 in all location or one location?
Is it possible to get this webinar video recording?
Is there pic in indonesia ?
Will this be clinical laboratory only, or will they also want to have environmental, animal, and newborn screening testing?
The RFP document indicates training for APHL and MOH personnel. Will the APHL staff be Indonesian residents or U.S. expats? Will they be “permanent” in Indonesia?
Does APHL have references to Indonesian IT resources who have medical or laboratory experience/expertise whom we could contact about partnering?
I assume the language will be Bahasa Indonesia. Will that be the only language? Does APHL have contacts who might be able to provide proper translation of the U.S. laboratory terminology on screens, etc. into proper Bahasa Indonesia?
The APHL estimated compensation is between $50,000 and $85,000 for the initial award for the project. Is this funding expected to cover Phase 1 or is it to cover other tasks and costs?
Will all contracting, including the possible need for in-country staff, be with APHL? The Foundation will need to know our exposure to non-USA organizations for the purpose of our liability insurance coverage.
The Foundation is currently beginning a project to develop an instrument interfacing module. When will this capability be required; Phase 1, 2, or later?
There are 4 laboratories in Phase 1. Can they share a single cloud implementation with their access secured as separate “sections” in the LIS or is their need for separation and security higher than that?
This project is supported by the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6.8 million dollars (COAG #NU2HGH000080, CFDA #93.318). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC, HHS, or the U.S. Government. For more information, please visit https://www.aphl.org/programs/global_health/Pages/default.aspx.